Login to Your Account

'Start your Angions': $35M to fuel therapies for organ injury

By Marie Powers
Staff Writer

Tuesday, April 15, 2014
Although the amounts are shrinking, biotechs are still seeking to squeeze through the initial public offering (IPO) window. After three filings last week in the hunt for a combined raise of $174 million, Angion Biomedica Corp. registered Monday with the SEC seeking up to $35 million, including overallotments.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription